Pharma Focus Asia

The University of Kansas Cancer Centre Opens New Cancer Research and Care Facility


The University of Kansas Cancer Centre received US$100 million as a gift from The Sunderland Foundation to construct a state-of-the-art cancer centre. The facility will be located in USA.


The new state-of-the-art cancer centre will expand capabilities that aims to enhance its capabilities, attract top doctors from around the world, conduct cutting-edge research, and provide innovative treatments to patients.

The new building will serve as a unified space for expanded cancer care and research. Moreover, the new building will indeed serve as a hub for leading-edge patient care and innovation. 

Furthermore, the new facility will consolidate various aspects of the patient experience under one roof. This means that services such as nutrition, social work, pathology, and imaging will be conveniently accessible in a single location. 

The centre will facilitate real-time collaboration between researchers and physicians, enabling the development and swift implementation of personalised treatment options for patients. In addition, the building has the potential to make a significant impact on cancer care at the national level.

The new facility will be developed in phases, with construction on the initial phase expected to begin in the fall of 2024.


Name        The University of Kansas Cancer Center
Type          New Construction
Year          Construction set to begin in 2024


magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference